TandemAI
TandemAI is transforming drug discovery by integrating generative AI, physics-based modeling (molecular dynamics and quantum mechanics), an AI-powered, next generation SaaS platform, TandemViz™, and large-scale chemistry and biology labs. This computation-first approach covers the entire drug development process, from target prediction to clinical candidate determination, significantly boosting efficiency and success rates for global pharmaceutical organizations.
Leadership & Board
- Current Number of Employees
- 51
- Current LinkedIn Followers
- 5,950
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $22M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $22M
- Latest Funding Round
- Series A
- Post-Money Valuation
- ―
Employee Trend
TandemAI had 51 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
TandemAI had 5,950 followers as of October 12, 2026. The number of followers increased by 26 (0.44%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Nov 14, 2025 | Series A | $22.00M | ― |
Similar Companies
A snapshot of private companies similar to TandemAI, helping you discover and navigate related company profiles.
Related News and Analysis
